Boston Scientific says EU approved heart device

Boston Scientific Inc., the Natick-based medical device maker, said that European Union regulators have approved a new system of wires used in implanted heart devices.

The company said its Endotak Reliance 4-site system received marketing approval, and is now being used in surgeries. Endotak Reliance is a series of wires that connect implanted defibrillators to the heart and deliver electric shocks to restore a normal heart rhythm.

Boston Scientific said its new device is smaller, combining three wire terminals into one connector. The leads are designed to be used with Boston Scientific's Teligen and Cognis heart devices.

In morning trading, Boston Scientific shares rose 25 cents, or 2.8 percent, to $9.32. (AP)